Compare drug alternatives
Invokamet ® Alternatives
Invokamet ®(Canagliflozin And Metformin Hydrochloride) | Inpefa®(Sotagliflozin) |
|---|---|
Prescription Only | Prescription Only |
| Dosage & Administration | Dosage & Administration comparison data |
Administration | |
Oral. Learn more. | Oral . Learn more. |
Dosing | |
One tablet, twice daily with meals, recommended starting dose of canagliflozin is 50 mg twice daily and metformin HCl 500 mg twice daily. Learn more. | 200 mg daily and titrate to 400 mg as tolerated.. Learn more. |
Latin Shorthand | |
1 tab BID with meals. Starting dose: canagliflozin 50 mg BID, metformin HCl 500 mg BID.. Learn more. | Take 200 mg qd, increase to 400 mg qd if tolerated.. Learn more. |
| Financial Assistance | Financial Assistance comparison data |
Out-Of-Pocket Costs With Copay Card | |
$0. Learn more. | $10. Learn more. |
Annual Cap | |
$3,000 and $200 per month. Learn more. | $2,600. Learn more. |
Assistance Expiration | |
Calendar year. Learn more. | 12/31/25. Learn more. |
Generics | |
No lower-cost generic available | No lower-cost generic available |
| Physician Advisory | Physician Advisory comparison data |
Adverse Reactions | |
Most common adverse reactions associated with canagliflozin (5% or
greater incidence): female genital mycotic infections, urinary tract
infection, and increased urination.
Most common adverse reactions associated with metformin HCl (5% or
greater incidence) are diarrhea, nausea, vomiting, flatulence, asthenia,
indigestion, abdominal discomfort, and headache. . Learn more. | Most common adverse reactions (incidence ≥ 5%) are urinary tract infection,
volume depletion, diarrhea, and hypoglycemia. . Learn more. |
Mechanism of Actions (MoA) | |
SGLT2 Inhibitors. Learn more. | SGLT2 Inhibitors. Learn more. |
Special Populations | |